Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Sanuwave Health ( (SNWV) ) is now available.
On August 19, 2025, Sanuwave Health held its annual meeting of stockholders where several key proposals were voted upon. The stockholders elected five directors, ratified the appointment of Baker Tilly US, LLP as the independent registered public accounting firm, approved an amendment to the 2024 Equity Incentive Plan to increase shares, and voted on executive compensation matters. These decisions reflect the company’s ongoing governance and strategic planning efforts.
The most recent analyst rating on (SNWV) stock is a Hold with a $41.00 price target. To see the full list of analyst forecasts on Sanuwave Health stock, see the SNWV Stock Forecast page.
Spark’s Take on SNWV Stock
According to Spark, TipRanks’ AI Analyst, SNWV is a Neutral.
Sanuwave Health’s overall stock score is driven by strong earnings call performance and positive technical indicators, offset by weak financial performance and unattractive valuation. The company’s revenue growth and product sales are promising, but financial instability and profitability challenges remain significant risks.
To see Spark’s full report on SNWV stock, click here.
More about Sanuwave Health
Average Trading Volume: 83,560
Technical Sentiment Signal: Buy
Current Market Cap: $328.7M
For a thorough assessment of SNWV stock, go to TipRanks’ Stock Analysis page.